Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome.
about
PPAR delta: a dagger in the heart of the metabolic syndrome.Body weight, lifestyle, dietary habits and gastroesophageal reflux diseaseEffect of exercise training intensity on abdominal visceral fat and body composition.Role of visceral adipose tissue in agingRole of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a reviewThe "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparisonHerbal Medicines for Treating Metabolic Syndrome: A Systematic Review of Randomized Controlled TrialsFetal programming and early identification of newborns at high risk of free radical-mediated diseasesAdipose tissue dysfunction in nascent metabolic syndromeNIH ImageJ and Slice-O-Matic computed tomography imaging software to quantify soft tissueSex and genetic effects on upper and lower body fat and associations with diabetes in multigenerational families of African heritageUncovering Factors Related to Pancreatic Beta-Cell FunctionA Randomized Trial on the Effect of Razavi's Dietary Pattern on the Components of Metabolic Syndrome.Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic targetPredicting total, abdominal, visceral and hepatic adiposity with circulating biomarkers in Caucasian and Japanese American women.Effects of continuous versus intermittent exercise, obesity, and gender on growth hormone secretion.Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth.The Prevalence of Metabolic Syndrome and Its Related Factors among Adults in Palestine: A Meta-Analysis.Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels.Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in miceIncreased plasma levels of retinol-binding protein 4 with visceral obesity is associated with cardiovascular risk factorsLong-term risperidone treatment induces visceral adiposity associated with hepatic steatosis in mice: a magnetic resonance approachMetabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness.Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort.Metabolic syndrome and associated factors in people with chronic obstructive pulmonary disease.Associations of visceral fat area and physical activity levels with the risk of metabolic syndrome in postmenopausal women.Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study.Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.Liver fat percent is associated with metabolic risk factors and the metabolic syndrome in a high-risk vascular cohortPrevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco.Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity.Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.MRI sagittal abdominal diameter is a stronger predictor of metabolic syndrome than visceral fat area or waist circumference in a high-risk vascular cohort.FTO is a relevant factor for the development of the metabolic syndrome in mice.Tissue-specific dysregulation of DNA methylation in aging.Associated factors for a hyperechogenic pancreas on endoscopic ultrasound.Fat tissue, aging, and cellular senescence.Genetic variations in the CYP17A1 and NT5C2 genes are associated with a reduction in visceral and subcutaneous fat areas in Japanese women.Toward a unifying hypothesis of metabolic syndrome.
P2860
Q24541527-D3DC446C-C1A9-4F82-BBB5-B4981501A16BQ24642676-76067EE5-9E6D-48A6-A2DC-A3155BE02A7BQ24648289-4A40F5AB-DD97-44F2-9D2B-B2F382E55FD0Q24654243-FD4E4038-DF0D-4B6E-B59C-67D98412F56BQ24801508-3FF5D332-E702-4F9D-A665-E818746B8864Q24816592-A7572551-04BE-4A9A-9EE3-7CBBC9938F89Q26740415-ABAF3B41-7A0F-45F9-8690-E94096E908E9Q26750488-89935C9A-7E41-47BB-B899-C925A482BAABQ27026065-26246C65-E8AD-4343-8D6A-E81DF7FEC85DQ28364530-56E9D22F-9514-4047-8DC4-1738C03CC01FQ28384907-0A73F850-E33B-4456-8F72-F0D6E8D7A9A0Q28553583-1DF8EA36-C607-4C44-B0CE-421110A5DC94Q30362579-CE361931-D264-44AC-9908-420E2BF67756Q30370672-BF067AA3-6C14-4FB3-B459-88E56746E8BCQ30425474-B6C96989-BA29-4102-AD68-1DB62628D8F0Q30437776-B5C80A84-041B-4CD4-A1D4-23B035A4B575Q33299455-6BD10027-3EB6-4D52-B280-3ACD0DF43BB5Q33559826-AA1069E5-00AB-4602-93C5-2146716ACE27Q33570400-F41ECE9A-F53E-4918-8220-5894B0A1EC98Q33580624-79FC2D53-0445-4BAF-BC7B-3C23445FADD3Q33585519-FB8DE441-BF94-4258-910D-024378CC2486Q33603314-5038AB2F-9B05-4C5B-A664-92A7204FDC47Q33607534-1AFD1261-4A5A-4A72-B31D-D1BC0E22C020Q33607601-11583749-99DD-40D0-A233-B8820701F3D6Q33651745-61AE5F1B-7DA5-44C3-9889-2EB1387C1DB8Q33652576-F0F456C3-C6C1-484E-AA53-728183D4E49CQ33695167-DF9D576E-B698-4063-884B-1259A50DBAA9Q33822049-326844D7-A75A-45F6-9EA0-12C7C6776603Q33946318-FFC01041-C3B5-404E-8DEF-AA0142F9738BQ33952051-0AA3FB7E-7921-456A-8B54-10F8BF4D31D3Q34011649-3BC451EF-CCF0-401F-921C-EA4614F90115Q34014004-0F813EAD-3CAB-470E-8CFB-CB07B0E4F4A4Q34020532-6B83AD21-0EE3-47A4-96AF-8E72C224C7F0Q34068779-F85052CA-8818-4EFD-B806-0C33192B22CAQ34075518-D3796869-F761-44F5-9DD7-A488E4A156EBQ34109390-5D48CF04-F337-43B8-8E17-F90E16E4D503Q34117855-B97BB4E7-667A-4194-AB61-AE2B317DCF81Q34130783-8E215EA6-4ABF-4FCF-AFCE-1E29687C5FD4Q34231237-E05C12D6-4BB0-47D1-956F-9B08FEE9B378Q34255878-F971C53A-27DB-4394-BA3E-F14F625BE4AB
P2860
Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Intra-abdominal fat is a major ...... ia for the metabolic syndrome.
@en
Intra-abdominal fat is a major ...... ia for the metabolic syndrome.
@nl
type
label
Intra-abdominal fat is a major ...... ia for the metabolic syndrome.
@en
Intra-abdominal fat is a major ...... ia for the metabolic syndrome.
@nl
prefLabel
Intra-abdominal fat is a major ...... ia for the metabolic syndrome.
@en
Intra-abdominal fat is a major ...... ia for the metabolic syndrome.
@nl
P2093
P1433
P1476
Intra-abdominal fat is a major ...... ia for the metabolic syndrome.
@en
P2093
Barbara M Retzlaff
Brian E Fish
Darcy B Carr
Jane B Shofer
John D Brunzell
Keiichi Kodama
Kristina M Utzschneider
Rebecca L Hull
Robert H Knopp
P304
P356
10.2337/DIABETES.53.8.2087
P407
P577
2004-08-01T00:00:00Z